Methodist Health System Clinical Research Institute

Dallas, Texas 75203

0 studies enrolling now · 7 studies all time

What they study most

Arterial Occlusive Diseases, Covid19, Decompensated Cirrhosis, Early Breast Cancer, Fracture, Fracture Nonunion, Fractures, Bone, Hiv, Liver Fibroses, Liver Inflammation, Liver Steatoses, Non-Alcoholic Fatty Liver Disease

Studies at this site

• Relationships Between Vitamin D and Orthopedic Trauma — Completed
• Efficacy and Safety Study of EG1206A (EirGenix' Pertuzumab) Compared With EU-sourced Perjeta® (Pertuzumab) in Patients With HER2-positive Hormone Receptor Negative Early Breast Cancer. — Withdrawn before enrolling
• HOPE in Action Prospective Multicenter, Clinical Trial of Deceased HIVD+ Kidney Transplants for HIV+ Recipients — Completed
• Immune Modulators for Treating COVID-19 — Completed
• Clinical Performance of LIVERFASt Test Compared w/ Liver Biopsy in Patients w/ NAFLD. — Completed
• Real-World Registry Assessing the Clinical Use of the Lutonix 035 Drug Coated Balloon Catheter — Completed
• Emricasan, a Caspase Inhibitor, for Treatment of Subjects With Decompensated NASH Cirrhosis — Status unconfirmed